TLDR Convano aims to acquire 21,000 BTC by 2027, holding 0.1% of Bitcoin’s total supply. The firm has raised 2% of its $3B goal and owns 365 BTC as of August 2025. Convano’s shares doubled after revealing its Bitcoin acquisition plan. Seven Japanese firms now rank among the top 100 public Bitcoin holders. A Japanese [...] The post Japanese Nail Salon Attempts Reinvention as Major Bitcoin Holder appeared first on CoinCentral.TLDR Convano aims to acquire 21,000 BTC by 2027, holding 0.1% of Bitcoin’s total supply. The firm has raised 2% of its $3B goal and owns 365 BTC as of August 2025. Convano’s shares doubled after revealing its Bitcoin acquisition plan. Seven Japanese firms now rank among the top 100 public Bitcoin holders. A Japanese [...] The post Japanese Nail Salon Attempts Reinvention as Major Bitcoin Holder appeared first on CoinCentral.

Japanese Nail Salon Attempts Reinvention as Major Bitcoin Holder

TLDR

  • Convano aims to acquire 21,000 BTC by 2027, holding 0.1% of Bitcoin’s total supply.
  • The firm has raised 2% of its $3B goal and owns 365 BTC as of August 2025.
  • Convano’s shares doubled after revealing its Bitcoin acquisition plan.
  • Seven Japanese firms now rank among the top 100 public Bitcoin holders.

A Japanese nail salon chain is making an unexpected move into the world of cryptocurrency. Convano Inc., once known only for beauty services, now plans to reinvent itself by becoming one of the largest corporate holders of Bitcoin. With a bold goal of acquiring 21,000 BTC by 2027, the company is raising $3 billion—betting that Bitcoin can protect its reserves from a weakening yen and rising economic uncertainty.

Convano Targets 21,000 BTC Amid Weak Yen

Convano Inc. has announced plans to purchase 21,000 Bitcoin by March 2027, aiming to secure 0.1% of the total BTC supply. The firm intends to raise 434 billion yen (around $3 billion) through equity and bond sales to fund the acquisition.

As of August 25, the company has raised about 2% of its target and currently holds 365 Bitcoin. Convano is following a phased approach, with plans to buy 2,000 BTC by 2025, 10,000 by 2026, and complete the goal by 2027. The average purchase price is estimated at 19.9 million yen per coin.

The decision is driven by the long-term decline of the Japanese yen, which has lost 21% of its value against the U.S. dollar over the past ten years. Rising costs in wages and raw materials have pushed Convano to look for alternative assets. “We started to think about Bitcoin because of the persistent yen depreciation and geopolitical risks,” said Director Taiyo Azuma.

Strategy Mirrors Models Used by Other Crypto-Focused Firms

Convano’s approach draws from a model popularized by MicroStrategy founder Michael Saylor. The strategy involves using investor interest to boost the company’s stock price and then converting the gains into capital to buy Bitcoin.

“We will enhance corporate value with the new plan, which will increase our stock price 10 times,” said Motokiyo Azuma, who leads Convano’s finance and crypto plans. Since the announcement, the company’s shares have more than doubled, signaling investor interest in the new direction.

Convano has already secured 4.5 billion yen through corporate bonds. Brokers Nomura Securities and SMBC Nikko Securities are expected to support the fundraising process. The company has not yet disclosed anchor investors or a full funding timeline.

Convano is one of several Japanese firms turning to Bitcoin amid low interest rates and limited returns from traditional assets like bonds. As of July 2025, seven Japan-based firms are listed among the top 100 Bitcoin-holding public companies.

Risks Include Volatility, Regulatory Pressure, and Focus Shift

Bitcoin’s price remains unstable, and critics warn that a sharp drop could reduce the value of Convano’s holdings. The plan also raises liquidity concerns, as a large portion of funds will be tied to one volatile asset.

The company’s reliance on Bitcoin could limit its ability to invest in core operations such as salon expansion or customer technology. Some analysts question whether such a strategy fits the company’s original business model.

Japan’s Financial Services Agency is also planning tighter rules on how firms report crypto holdings. New reporting standards may increase costs and reduce flexibility for companies holding Bitcoin in large volumes.

Convano’s pivot comes at a time when other firms are testing similar strategies. Metaplanet, another Japan-based company, has already acquired around 19,000 BTC. Still, not all firms succeed with this shift. For example, crypto-focused firm Ethzilla lost more than half its value shortly after changing direction.

The post Japanese Nail Salon Attempts Reinvention as Major Bitcoin Holder appeared first on CoinCentral.

Market Opportunity
Bitcoin Logo
Bitcoin Price(BTC)
$95,499.9
$95,499.9$95,499.9
-1.31%
USD
Bitcoin (BTC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26